{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["drug discovery", "kinase activator", "molecular dynamics simulations", "phytoconstituents", "principal component analysis", "pyruvate kinase M2", "tuberosin", "virtual screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36361954", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "29"}], "Language": ["eng"], "ELocationID": ["13172", "10.3390/ijms232113172"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "21", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "29"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.", "Abstract": {"AbstractText": ["Metabolic reprogramming is a key attribute of cancer progression. An altered expression of pyruvate kinase M2 (PKM2), a phosphotyrosine-binding protein is observed in many human cancers. PKM2 plays a vital role in metabolic reprogramming, transcription and cell cycle progression and thus is deliberated as an attractive target in anticancer drug development. The expression of PKM2 is essential for aerobic glycolysis and cell proliferation, especially in cancer cells, facilitating selective targeting of PKM2 in cell metabolism for cancer therapeutics. We have screened a virtual library of phytochemicals from the IMPPAT (Indian Medicinal Plants, Phytochemistry and Therapeutics) database of Indian medicinal plants to identify potential activators of PKM2. The initial screening was carried out for the physicochemical properties of the compounds, and then structure-based molecular docking was performed to select compounds based on their binding affinity towards PKM2. Subsequently, the ADMET (absorption, distribution, metabolism, excretion and toxicity) properties, PAINS (Pan-assay interference compounds) patterns, and PASS evaluation were carried out to find more potent hits against PKM2. Here, Tuberosin was identified from the screening process bearing appreciable binding affinity toward the PKM2-binding pocket and showed a worthy set of drug-like properties. Finally, molecular dynamics simulation for 100 ns was performed, which showed decent stability of the protein-ligand complex and relatival conformational dynamics throughout the trajectory. The study suggests that modulating PKM2 with natural compounds is an attractive approach in treating human malignancy after required validation."]}, "AuthorList": [{"Identifier": ["0000-0002-7080-6822"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Molecular Diagnostics and Personalized Therapeutics Unit, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia."}], "LastName": "Adnan", "ForeName": "Mohd", "Initials": "M"}, {"Identifier": ["0000-0001-7055-7056"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Shamsi", "ForeName": "Anas", "Initials": "A"}, {"Identifier": ["0000-0002-7003-9846"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, Sakaka P.O. Box 72388, Saudi Arabia."}], "LastName": "Elasbali", "ForeName": "Abdelbaset Mohamed", "Initials": "AM"}, {"Identifier": ["0000-0002-6236-0920"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia."}], "LastName": "Siddiqui", "ForeName": "Arif Jamal", "Initials": "AJ"}, {"Identifier": ["0000-0002-9283-2124"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India."}], "LastName": "Patel", "ForeName": "Mitesh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia."}], "LastName": "Alshammari", "ForeName": "Nawaf", "Initials": "N"}, {"Identifier": ["0000-0002-0352-6900"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Science, College of Arts and Science, Najran University, Najran P.O. Box 11001, Saudi Arabia."}], "LastName": "Alharethi", "ForeName": "Salem Hussain", "Initials": "SH"}, {"Identifier": ["0000-0002-7174-9831"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Science, College of Applied Medical Sciences-Sakaka, Jouf University, Sakaka P.O. Box 72388, Saudi Arabia."}], "LastName": "Alhassan", "ForeName": "Hassan H", "Initials": "HH"}, {"Identifier": ["0000-0003-3377-2763"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia."}], "LastName": "Bardakci", "ForeName": "Fevzi", "Initials": "F"}, {"Identifier": ["0000-0002-3663-4940"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Hassan", "ForeName": "Md Imtaiyaz", "Initials": "MI"}], "GrantList": [{"GrantID": "MDR-22003", "Agency": "University of Hail", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Activators"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphate-Binding Proteins"}, {"RegistryNumber": "EC 2.7.1.40", "NameOfSubstance": "Pyruvate Kinase"}, {"RegistryNumber": "0", "NameOfSubstance": "tuberosinine D"}, {"RegistryNumber": "0", "NameOfSubstance": "tuberosin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Enzyme Activators"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Glycosides"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Isoflavones"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Phosphate-Binding Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Pyruvate Kinase"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Griffin J.L., Shockcor J.P. Metabolic profiles of cancer cells. Nat. Rev. Cancer. 2004;4:551\u2013561. doi: 10.1038/nrc1390.", "ArticleIdList": ["10.1038/nrc1390", "15229480"]}, {"Citation": "Martinez-Outschoorn U.E., Peiris-Pag\u00e9s M., Pestell R.G., Sotgia F., Lisanti M.P. Cancer metabolism: A therapeutic perspective. Nat. Rev. Clin. Oncol. 2017;14:11\u201331. doi: 10.1038/nrclinonc.2016.60.", "ArticleIdList": ["10.1038/nrclinonc.2016.60", "27141887"]}, {"Citation": "Christofk H.R., Heiden M.G.V., Wu N., Asara J.M., Cantley L.C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature. 2008;452:181\u2013186. doi: 10.1038/nature06667.", "ArticleIdList": ["10.1038/nature06667", "18337815"]}, {"Citation": "Yang W., Lu Z. Pyruvate kinase M2 at a glance. J. Cell Sci. 2015;128:1655\u20131660. doi: 10.1242/jcs.166629.", "ArticleIdList": ["10.1242/jcs.166629", "PMC4446733", "25770102"]}, {"Citation": "Yang W., Lu Z. Regulation and function of pyruvate kinase M2 in cancer. Cancer Lett. 2013;339:153\u2013158. doi: 10.1016/j.canlet.2013.06.008.", "ArticleIdList": ["10.1016/j.canlet.2013.06.008", "PMC3950276", "23791887"]}, {"Citation": "Li Y.-H., Li X.-F., Liu J.-T., Wang H., Fan L.-L., Li J., Sun G.-P. PKM2, a potential target for regulating cancer. Gene. 2018;668:48\u201353. doi: 10.1016/j.gene.2018.05.038.", "ArticleIdList": ["10.1016/j.gene.2018.05.038", "29775756"]}, {"Citation": "Zhu S., Guo Y., Zhang X., Liu H., Yin M., Chen X., Peng C. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Cancer Lett. 2021;503:240\u2013248. doi: 10.1016/j.canlet.2020.11.018.", "ArticleIdList": ["10.1016/j.canlet.2020.11.018", "33246091"]}, {"Citation": "Zahra K., Dey T., Mishra S.P., Pandey U. Pyruvate kinase M2 and cancer: The role of PKM2 in promoting tumorigenesis. Front. Oncol. 2020;10:159. doi: 10.3389/fonc.2020.00159.", "ArticleIdList": ["10.3389/fonc.2020.00159", "PMC7061896", "32195169"]}, {"Citation": "Chen J., Xie J., Jiang Z., Wang B., Wang Y., Hu X. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2. Oncogene. 2011;30:4297\u20134306. doi: 10.1038/onc.2011.137.", "ArticleIdList": ["10.1038/onc.2011.137", "21516121"]}, {"Citation": "Varghese B., Swaminathan G., Plotnikov A., Tzimas C., Yang N., Rui H., Fuchs S.Y. Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation. Mol. Endocrinol. 2010;24:2356\u20132365. doi: 10.1210/me.2010-0219.", "ArticleIdList": ["10.1210/me.2010-0219", "PMC2999476", "20962042"]}, {"Citation": "Chaneton B., Hillmann P., Zheng L., Martin A.C.L., Maddocks O.D.K., Chokkathukalam A., Coyle J.E., Jankevics A., Holding F.P., Vousden K.H., et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature. 2012;491:458\u2013462. doi: 10.1038/nature11540.", "ArticleIdList": ["10.1038/nature11540", "PMC3894725", "23064226"]}, {"Citation": "Morgan H.P., O\u2019Reilly F.J., Wear M.A., O\u2019Neill J.R., Fothergill-Gilmore L.A., Hupp T., Walkinshaw M.D. M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc. Natl. Acad. Sci. USA. 2013;110:5881\u20135886. doi: 10.1073/pnas.1217157110.", "ArticleIdList": ["10.1073/pnas.1217157110", "PMC3625322", "23530218"]}, {"Citation": "Kefas B., Comeau L., Erdle N., Montgomery E., Amos S., Purow B. Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. Neuro Oncol. 2010;12:1102\u20131112. doi: 10.1093/neuonc/noq080.", "ArticleIdList": ["10.1093/neuonc/noq080", "PMC3098027", "20667897"]}, {"Citation": "Shi H.-S., Li D., Zhang J., Wang Y.-S., Yang L., Zhang H.-L., Wang X., Mu B., Wang W., Ma Y., et al. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice. Cancer Sci. 2010;101:1447\u20131453. doi: 10.1111/j.1349-7006.2010.01562.x.", "ArticleIdList": ["10.1111/j.1349-7006.2010.01562.x", "20507318"]}, {"Citation": "Guo W., Zhang Y., Chen T., Wang Y., Xue J., Zhang Y., Xiao W., Mo X., Lu Y. Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model. J. Cancer Res. Clin. Oncol. 2011;137:65\u201372. doi: 10.1007/s00432-010-0860-5.", "ArticleIdList": ["10.1007/s00432-010-0860-5", "20336315"]}, {"Citation": "Hatoum D., Haddadi N., Lin Y., Nassif N.T., McGowan E.M. Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: Challenges for SphK as an oncotarget. Oncotarget. 2017;8:36898\u201336929. doi: 10.18632/oncotarget.16370.", "ArticleIdList": ["10.18632/oncotarget.16370", "PMC5482707", "28415564"]}, {"Citation": "Wang P., Sun C., Zhu T., Xu Y. Structural insight into mechanisms for dynamic regulation of PKM2. Protein Cell. 2015;6:275\u2013287. doi: 10.1007/s13238-015-0132-x.", "ArticleIdList": ["10.1007/s13238-015-0132-x", "PMC4383751", "25645022"]}, {"Citation": "Heiden M.G.V., Christofk H.R., Schuman E., Subtelny A.O., Sharfi H., Harlow E.E., Xian J., Cantley L.C. Identification of small molecule inhibitors of pyruvate kinase M2. Biochem. Pharmacol. 2010;79:1118\u20131124. doi: 10.1016/j.bcp.2009.12.003.", "ArticleIdList": ["10.1016/j.bcp.2009.12.003", "PMC2823991", "20005212"]}, {"Citation": "Matsui Y., Yasumatsu I., Asahi T., Kitamura T., Kanai K., Ubukata O., Hayasaka H., Takaishi S., Hanzawa H., Katakura S. Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator. Bioorganic Med. Chem. 2017;25:3540\u20133546. doi: 10.1016/j.bmc.2017.05.004.", "ArticleIdList": ["10.1016/j.bmc.2017.05.004", "28511909"]}, {"Citation": "Mohammad T., Siddiqui S., Shamsi A., Alajmi M.F., Hussain A., Islam A., Ahmad F., Hassan M.I. Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and simulation studies. Molecules. 2020;25:823. doi: 10.3390/molecules25040823.", "ArticleIdList": ["10.3390/molecules25040823", "PMC7070812", "32070031"]}, {"Citation": "Mohammad T., Khan F.I., Lobb K.A., Islam A., Ahmad F., Hassan M.I. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4) J. Biomol. Struct. Dyn. 2019;37:1813\u20131829. doi: 10.1080/07391102.2018.1468282.", "ArticleIdList": ["10.1080/07391102.2018.1468282", "29683402"]}, {"Citation": "Naqvi A.A., Mohammad T., Hasan G.M., Hassan M. Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Top. Med. Chem. 2018;18:1755\u20131768. doi: 10.2174/1568026618666181025114157.", "ArticleIdList": ["10.2174/1568026618666181025114157", "30360721"]}, {"Citation": "Kim S., Thiessen P.A., Bolton E.E., Chen J., Fu G., Gindulyte A., Han L., He J., He S., Shoemaker B.A., et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202\u2013D1213. doi: 10.1093/nar/gkv951.", "ArticleIdList": ["10.1093/nar/gkv951", "PMC4702940", "26400175"]}, {"Citation": "Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36:D901\u2013D906. doi: 10.1093/nar/gkm958.", "ArticleIdList": ["10.1093/nar/gkm958", "PMC2238889", "18048412"]}, {"Citation": "Irwin J.J., Shoichet B.K. ZINC\u2014A free database of commercially available compounds for virtual screening. J. Chem. Inf. Modeling. 2005;45:177\u2013182. doi: 10.1021/ci049714+.", "ArticleIdList": ["10.1021/ci049714+", "PMC1360656", "15667143"]}, {"Citation": "Mohanraj K., Karthikeyan B.S., Vivek-Ananth R.P., Chand R.P., Aparna S.R., Mangalapandi P., Samal A. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry and Therapeutics. Sci. Rep. 2018;8:4329. doi: 10.1038/s41598-018-22631-z.", "ArticleIdList": ["10.1038/s41598-018-22631-z", "PMC5847565", "29531263"]}, {"Citation": "Mohammad T., Shamsi A., Anwar S., Umair M., Hussain A., Rehman M.T., AlAjmi M.F., Islam A., Hassan M.I. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy. Virus Res. 2020;288:198102. doi: 10.1016/j.virusres.2020.198102.", "ArticleIdList": ["10.1016/j.virusres.2020.198102", "PMC7380256", "32717346"]}, {"Citation": "Koparde A.A., Doijad R.C., Magdum C.S. Pharmacognosy\u2014Medicinal Plants. IntechOpen; London, UK: 2019. Natural Products in Drug Discovery."}, {"Citation": "Anjum F., Mohammad T., Almalki A.A., Akhtar O., Abdullaev B., Hassan M.I. Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase. OMICS J. Integr. Biol. 2021;25:580\u2013590. doi: 10.1089/omi.2021.0107.", "ArticleIdList": ["10.1089/omi.2021.0107", "34448628"]}, {"Citation": "Misteli T. Protein dynamics: Implications for nuclear architecture and gene expression. Science. 2001;291:843\u2013847. doi: 10.1126/science.291.5505.843.", "ArticleIdList": ["10.1126/science.291.5505.843", "11225636"]}, {"Citation": "Dahiya R., Mohammad T., Gupta P., Haque A., Alajmi M.F., Hussain A., Hassan I. Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3. RSC Adv. 2019;9:23302\u201323315. doi: 10.1039/C9RA02864A.", "ArticleIdList": ["10.1039/C9RA02864A", "PMC9067284", "35514501"]}, {"Citation": "Kuzmanic A., Zagrovic B. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys. J. 2010;98:861\u2013871. doi: 10.1016/j.bpj.2009.11.011.", "ArticleIdList": ["10.1016/j.bpj.2009.11.011", "PMC2830444", "20197040"]}, {"Citation": "Amir M., Mohammad T., Prasad K., Hasan G.M., Kumar V., Dohare R., Islam A., Ahmad F., Hassan I. Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1) J. Biomol. Struct. Dyn. 2020;38:4625\u20134634. doi: 10.1080/07391102.2019.1682052.", "ArticleIdList": ["10.1080/07391102.2019.1682052", "31625455"]}, {"Citation": "Lobanov M.Y., Bogatyreva N., Galzitskaya O. Radius of gyration as an indicator of protein structure compactness. Mol. Biol. 2008;42:623\u2013628. doi: 10.1134/S0026893308040195.", "ArticleIdList": ["10.1134/S0026893308040195", "18856071"]}, {"Citation": "Kumar B., Mohammad T., Uddin A., Hussain A., Islam A., Ahmad F., Alajmi M.F., Singh S., Pandey K.C., Hassan I., et al. Targeting metacaspase-3 from Plasmodium falciparum towards antimalarial therapy: A combined approach of in-silico and in-vitro investigation. J. Biomol. Struct. Dyn. 2021;39:421\u2013430. doi: 10.1080/07391102.2019.1711194.", "ArticleIdList": ["10.1080/07391102.2019.1711194", "31900062"]}, {"Citation": "Gupta P., Khan S., Fakhar Z., Hussain A., Rehman M., AlAjmi M.F., Islam A., Ahmad F., Hassan M. Identification of potential inhibitors of calcium/calmodulin-dependent protein kinase IV from bioactive phytoconstituents. Oxidative Med. Cell. Longev. 2020;2020:2094635. doi: 10.1155/2020/2094635.", "ArticleIdList": ["10.1155/2020/2094635", "PMC7382742", "32724490"]}, {"Citation": "Naqvi A.A.T., Hassan M.I. Oncology: Breakthroughs in Research and Practice. IGI Global; Hershey, PA, USA: 2017. Methods for Docking and Drug Designing; pp. 876\u2013890."}, {"Citation": "Mazola Y., Guirola O., Palomares S., Chinea G., Men\u00e9ndez C., Hern\u00e1ndez L., Musacchio A. A comparative molecular dynamics study of thermophilic and mesophilic \u03b2-fructosidase enzymes. J. Mol. Modeling. 2015;21:228. doi: 10.1007/s00894-015-2772-4.", "ArticleIdList": ["10.1007/s00894-015-2772-4", "26267297"]}, {"Citation": "Hubbard R.E., Haider M.K. Hydrogen bonds in proteins: Role and strength. eLS. 2010 doi: 10.1002/9780470015902.a0003011.pub2.", "ArticleIdList": ["10.1002/9780470015902.a0003011.pub2"]}, {"Citation": "Mohammad T., Amir M., Prasad K., Batra S., Kumar V., Hussain A., Rehman T., AlAjmi M.F., Hassan I. Impact of amino acid substitution in the kinase domain of Bruton tyrosine kinase and its association with X-linked agammaglobulinemia. Int. J. Biol. Macromol. 2020;164:2399\u20132408. doi: 10.1016/j.ijbiomac.2020.08.057.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.08.057", "32784026"]}, {"Citation": "Wei G., Xi W., Nussinov R., Ma B. Protein ensembles: How does nature harness thermodynamic fluctuations for life? The diverse functional roles of conformational ensembles in the cell. Chem. Rev. 2016;116:6516\u20136551. doi: 10.1021/acs.chemrev.5b00562.", "ArticleIdList": ["10.1021/acs.chemrev.5b00562", "PMC6407618", "26807783"]}, {"Citation": "Fatima S., Mohammad T., Jairajpuri D.S., Rehman T., Hussain A., Samim M., Ahmad F., Alajmi M.F., Hassan I. Identification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brain. J. Biomol. Struct. Dyn. 2020;38:3610\u20133620. doi: 10.1080/07391102.2019.1664937.", "ArticleIdList": ["10.1080/07391102.2019.1664937", "31496427"]}, {"Citation": "Amadei A., Linssen A.B., Berendsen H.J. Essential dynamics of proteins. Proteins Struct. Funct. Bioinform. 1993;17:412\u2013425. doi: 10.1002/prot.340170408.", "ArticleIdList": ["10.1002/prot.340170408", "8108382"]}, {"Citation": "Mallamace F., Corsaro C., Mallamace D., Vasi S., Vasi C., Baglioni P., Buldyrev S.V., Chen S.H., Stanley H.E. Energy landscape in protein folding and unfolding. Proc. Natl. Acad. Sci. USA. 2016;113:3159\u20133163. doi: 10.1073/pnas.1524864113.", "ArticleIdList": ["10.1073/pnas.1524864113", "PMC4812744", "26957601"]}, {"Citation": "Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis. 1997;18:2714\u20132723. doi: 10.1002/elps.1150181505.", "ArticleIdList": ["10.1002/elps.1150181505", "9504803"]}, {"Citation": "Lipinski C.A. Lead-and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 2004;1:337\u2013341. doi: 10.1016/j.ddtec.2004.11.007.", "ArticleIdList": ["10.1016/j.ddtec.2004.11.007", "24981612"]}, {"Citation": "Mohammad T., Mathur Y., Hassan M.I. InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief. Bioinform. 2020;22:bbaa279. doi: 10.1093/bib/bbaa279.", "ArticleIdList": ["10.1093/bib/bbaa279", "33105480"]}, {"Citation": "Biovia D.S. Discovery Studio Modeling Environment, Release 4.5. Dassault Syst\u00e8mes; San Diego, CA, USA: 2015."}, {"Citation": "DeLano W.L. Pymol: An open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 2002;40:82\u201392."}, {"Citation": "Van Der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J. GROMACS: Fast, flexible, and free. J. Comput. Chem. 2005;26:1701\u20131718. doi: 10.1002/jcc.20291.", "ArticleIdList": ["10.1002/jcc.20291", "16211538"]}, {"Citation": "Turner P. XMGRACE. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology; Beaverton, OR, USA: 2005. Version 5.1. 19."}, {"Citation": "Pires D.E., Blundell T.L., Ascher D.B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Baell J.B. Feeling nature\u2019s PAINS: Natural products, natural product drugs, and pan assay interference compounds (PAINS) J. Nat. Prod. 2016;79:616\u2013628. doi: 10.1021/acs.jnatprod.5b00947.", "ArticleIdList": ["10.1021/acs.jnatprod.5b00947", "26900761"]}, {"Citation": "Arunkumar R., Sharmila G., Elumalai P., Senthilkumar K., Banudevi S., Gunadharini D., Benson C., Daisy P., Arunakaran J. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis. Phytomedicine. 2012;19:912\u2013923. doi: 10.1016/j.phymed.2012.04.009.", "ArticleIdList": ["10.1016/j.phymed.2012.04.009", "22739413"]}, {"Citation": "Lagunin A., Stepanchikova A., Filimonov D., Poroikov V. PASS: Prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16:747\u2013748. doi: 10.1093/bioinformatics/16.8.747.", "ArticleIdList": ["10.1093/bioinformatics/16.8.747", "11099264"]}, {"Citation": "Discovery Studio . Discovery Studio. Accelrys Inc.; San Diego, CA, USA: 2008."}, {"Citation": "Abraham M.J., Murtola T., Schulz R., P\u00e1ll S., Smith J.C., Hess B., Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Sch\u00fcttelkopf A.W., Van Aalten D.M. PRODRG: A tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Crystallogr. Sect. D Biol. Crystallogr. 2004;60:1355\u20131363. doi: 10.1107/S0907444904011679.", "ArticleIdList": ["10.1107/S0907444904011679", "15272157"]}, {"Citation": "Altis A., Otten M., Nguyen P.H., Hegger R., Stock G. Construction of the free energy landscape of biomolecules via dihedral angle principal component analysis. J. Chem. Phys. 2008;128:245102. doi: 10.1063/1.2945165.", "ArticleIdList": ["10.1063/1.2945165", "18601386"]}, {"Citation": "Genheden S., Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 2015;10:449\u2013461. doi: 10.1517/17460441.2015.1032936.", "ArticleIdList": ["10.1517/17460441.2015.1032936", "PMC4487606", "25835573"]}, {"Citation": "Kumari R., Kumar R., Consortium O.S.D.D., Lynn A. g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Modeling. 2014;54:1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "24"}, {"Year": "2022", "Month": "9", "Day": "30"}, {"Year": "2022", "Month": "10", "Day": "6"}, {"Year": "2022", "Month": "11", "Day": "11", "Hour": "1", "Minute": "26"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["36361954", "PMC9655700", "10.3390/ijms232113172", "ijms232113172"]}}], "PubmedBookArticle": []}